Agile Therapeutics Announces Peer-Reviewed Publication of Phase 3 SECURE Study Results for Twirla® (levonorgestrel and ethinyl estradiol) Transdermal System in Contraception

    NEXT STORY
    Iterum Therapeutics Submits New Drug Application to U.S. Food and Drug Administration for Oral Sulopenem
    PREV STORY
    Philips introduces next generation of Advanced Visualization Workspace – IntelliSpace Portal 12 – with AI capabilities at RSNA 2020
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    PMV Pharma Appoints Leila Alland, M.D., as Chief Medical Officer

    author_avatar
    NASDAQ Market News

    Basilea shareholders approve all proposals of the Board of Directors at the Annual General Meeting

    author_avatar
    NASDAQ Market News

    Roche launches new VENTANA HER2 Dual ISH companion diagnostic test for breast and gastric cancer patients eligible for targeted therapy

    author_avatar
    NASDAQ Market News